Clinical trial
Clinical Implementation of TNM-immunoscore in Resected Non-small Cell Lung Cancer
NCT03299478 is registered in ClinicalTrials.gov with University Hospital of North Norway as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Implementation of TNM-immunoscore in Resected Non-small Cell Lung Cancer
- Lead sponsor
- University Hospital of North Norway
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- November 28, 2016
- Completion date
- February 1, 2027
- Enrollment
- 865 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
non-small cell lung cancer